Literature DB >> 32550212

Intestinal effect of the probiotic Escherichia coli strain Nissle 1917 and its OMV.

Ava Behrouzi1,2, Hoora Mazaheri3, Sarvenaz Falsafi4, Zahra Hoseini Tavassol1,2, Arfa Moshiri5,6, Seyed Davar Siadat1,2,7.   

Abstract

Several investigations have been conducted during the past years to examine the correlation between dysbiosis and both intestinal and extra-intestinal diseases such as inflammatory bowel disease (IBD) and ulcerative colitis (UC). E. coli Nissle 1917 (EcN) is a nonpathogenic gram-negative strain utilized in numerous gastrointestinal issues, consisting of diarrhea, uncomplicated diverticular malady, IBD and specifically UC. Many investigations have been done to examine the capability of assertive bacteria, inclusive of commensal and probiotic strains to enhance IBD in clinical testing. Bacterial secreted factors have been investigated to detect the EcN agents that facilitate the regulation of tight junction. These agents candiffuse smoothly through the mucin layer before reaching intestinal epithelial cells. Outer membrane vesicles (OMVs) are known as intercellular communicasomes as they facilitate the distal transfer of active compounds between cells. A few investigations have detailed immune-modulatory attributes for EcN through various systems that could be liable for its clinical viability in IBD. Today, the function of gut microbiota extracellular vesicles in health and disease has become a focus of attention as they serve as vehicles for the transmission of microorganisms to distal tissues of many bacterial effectors. © Springer Nature Switzerland AG 2020.

Entities:  

Year:  2020        PMID: 32550212      PMCID: PMC7271297          DOI: 10.1007/s40200-020-00511-6

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  86 in total

Review 1.  Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update.

Authors:  Franco Scaldaferri; Viviana Gerardi; Francesca Mangiola; Loris Riccardo Lopetuso; Marco Pizzoferrato; Valentina Petito; Alfredo Papa; Jovana Stojanovic; Andrea Poscia; Giovanni Cammarota; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

2.  Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling.

Authors:  Andreas Sturm; Klaus Rilling; Daniel C Baumgart; Konstantinos Gargas; Tay Abou-Ghazalé; Bärbel Raupach; Jana Eckert; Ralf R Schumann; Corinne Enders; Ulrich Sonnenborn; Bertram Wiedenmann; Axel U Dignass
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

3.  Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair.

Authors:  Agata A Zyrek; Christoph Cichon; Simone Helms; Corinne Enders; Ulrich Sonnenborn; M Alexander Schmidt
Journal:  Cell Microbiol       Date:  2006-11-03       Impact factor: 3.715

4.  NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium.

Authors:  Jan Wehkamp; Jürgen Harder; Kai Wehkamp; Birte Wehkamp-von Meissner; Miriam Schlee; Corinne Enders; Ulrich Sonnenborn; Sabine Nuding; Stig Bengmark; Klaus Fellermann; Jens Michael Schröder; Eduard F Stange
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

5.  Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion.

Authors:  J L Kadurugamuwa; T J Beveridge
Journal:  J Bacteriol       Date:  1995-07       Impact factor: 3.490

6.  Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function.

Authors:  K C Johnson-Henry; K A Donato; G Shen-Tu; M Gordanpour; P M Sherman
Journal:  Infect Immun       Date:  2008-01-28       Impact factor: 3.441

Review 7.  Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood-Adulthood Transition.

Authors:  Lorenza Putignani; Federica Del Chierico; Pamela Vernocchi; Michele Cicala; Salvatore Cucchiara; Bruno Dallapiccola
Journal:  Inflamm Bowel Dis       Date:  2016-02       Impact factor: 5.325

8.  Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model.

Authors:  Rebeca Martín; Sylvie Miquel; Florian Chain; Jane M Natividad; Jennifer Jury; Jun Lu; Harry Sokol; Vassilia Theodorou; Premysl Bercik; Elena F Verdu; Philippe Langella; Luis G Bermúdez-Humarán
Journal:  BMC Microbiol       Date:  2015-03-21       Impact factor: 3.605

9.  Salivary microRNAs as promising biomarkers for detection of esophageal cancer.

Authors:  Zijun Xie; Gang Chen; Xuchao Zhang; Dongfeng Li; Jian Huang; Cuiqin Yang; Pingyong Zhang; Yuxuan Qin; Yifan Duan; Bo Gong; Zijun Li
Journal:  PLoS One       Date:  2013-04-01       Impact factor: 3.240

10.  Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity.

Authors:  Sya N Ukena; Anurag Singh; Ulrike Dringenberg; Regina Engelhardt; Ursula Seidler; Wiebke Hansen; André Bleich; Dunja Bruder; Anke Franzke; Gerhard Rogler; Sebastian Suerbaum; Jan Buer; Florian Gunzer; Astrid M Westendorf
Journal:  PLoS One       Date:  2007-12-12       Impact factor: 3.240

View more
  3 in total

Review 1.  Neuroimmunomodulation by gut bacteria: Focus on inflammatory bowel diseases.

Authors:  Surbhi Aggarwal; Raju Ranjha; Jaishree Paul
Journal:  World J Gastrointest Pathophysiol       Date:  2021-05-22

Review 2.  Native and Engineered Probiotics: Promising Agents against Related Systemic and Intestinal Diseases.

Authors:  Haokun Shen; Zitong Zhao; Zengjue Zhao; Yuyi Chen; Linghua Zhang
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

3.  Cross-Talk between Probiotic Nissle 1917 and Human Colonic Epithelium Affects the Metabolite Composition and Demonstrates Host Antibacterial Effect.

Authors:  Karol Dokladny; John K Crane; Alex J Kassicieh; James B Kaper; Olga Kovbasnjuk
Journal:  Metabolites       Date:  2021-12-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.